Basit öğe kaydını göster

dc.contributor.authorMursalova, Zhala
dc.contributor.authorMursalova, Zhala
dc.date.accessioned2021-03-05T08:32:02Z
dc.date.available2021-03-05T08:32:02Z
dc.date.issued2020
dc.identifier.citationMursalova Z., Mursalova Z., "TO WHOM WE PRESCRIBE LONG ACTING ANTPSYCHOTICS AT DISCHARGE FROM HOSPITAL?", Schizophrenia Bulletin, cilt.46, no.209, ss.216, 2020
dc.identifier.issn0586-7614
dc.identifier.otherav_995b2b52-3f0e-42ff-9bca-81211847aef9
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/103139
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/995b2b52-3f0e-42ff-9bca-81211847aef9/file
dc.description.abstractBackground: Although the growing evidence show the advantages of longacting injectable (LAI)antipsychotics on treatment of psychotic disorders,characteristics of the patients with psychotic disorders using LAI is notstudied enough. The aim of this retrospective study is to understand theclinical characteristics of the patients with psychotic disorders to whom anyLAI was prescribed at discharge from hospital
dc.language.isoeng
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectSağlık Bilimleri
dc.titleTO WHOM WE PRESCRIBE LONG ACTING ANTPSYCHOTICS AT DISCHARGE FROM HOSPITAL?
dc.typeMakale
dc.relation.journalSchizophrenia Bulletin
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp
dc.identifier.volume46
dc.identifier.issue46
dc.identifier.startpage216
dc.identifier.endpage216
dc.contributor.firstauthorID2262682


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster